University of Minnesota
https://twin-cities.umn.edu/
612-625-5000

Policy, Financing, and Regulation

Policy, financing, and regulation milestones entail strategies for enhancing influenza vaccine investment, promoting innovation in influenza vaccine research and development (R&D), improving coordination of research and information sharing, and addressing regulatory challenges for assessing broadly protective or universal influenza vaccines.

Milestones completed
5
Milestones in progress
11
Milestones not started
5
Goals
Strategic goal
6.1

Support and funding

Catalyze broad support and sustained funding for developing improved seasonal influenza vaccines and broadly protective or universal influenza vaccines.

Milestones
6.1.a
High priority

Full value assessment (FVIVA)

6.1.b
High priority

Communications and advocacy

6.1.c
Ongoing

R&D funding tracker

6.1.d

Sustainable R&D

Strategic goal
6.2

Promoting innovation

Promote innovation for developing improved seasonal influenza vaccines and broadly protective or universal influenza vaccines.

Milestones
6.2.a
High priority

Lessons from COVID-19 R&D

6.2.b

Strategies to de-risk R&D

6.2.c

Summary of critical evidence

6.2.d

Global health equity

Strategic goal
6.3

Information sharing

Promote information sharing aimed at moving influenza vaccine development forward.

Milestones
6.3.a
Ongoing

Technology landscape

6.3.b
High priority

Impact of Nagoya Protocol

6.3.c

Data management and sharing

6.3.d

Intellectual property mapping

6.3.e

Sharing proprietary technologies

6.3.f

Harmonized data standards

Strategic goal
6.4

Regulatory challenges

Address regulatory challenges in the evaluation and licensure of next-generation, broadly protective, and universal influenza vaccines.

Milestones
6.4.a
High priority

Regulatory science issues

6.4.b

Post-marketing assessment

6.4.c

CHIVIM studies for licensure

6.4.d

Clinical endpoints for severe disease

6.4.e
Ongoing

Disease severity assessment

6.4.f

Correlate of protection for severe disease

6.4.g

Demonstration of VE against severe disease